1. Home
  2. LWAY vs ELDN Comparison

LWAY vs ELDN Comparison

Compare LWAY & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LWAY

Lifeway Foods Inc.

HOLD

Current Price

$18.30

Market Cap

283.3M

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$2.83

Market Cap

229.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LWAY
ELDN
Founded
1986
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
283.3M
229.3M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
LWAY
ELDN
Price
$18.30
$2.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$35.00
$8.50
AVG Volume (30 Days)
46.1K
1.3M
Earning Date
03-17-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
48.33
30.67
EPS
0.89
N/A
Revenue
$103,350,000.00
N/A
Revenue This Year
$15.20
N/A
Revenue Next Year
$16.67
N/A
P/E Ratio
$20.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.31
$1.35
52 Week High
$34.20
$4.60

Technical Indicators

Market Signals
Indicator
LWAY
ELDN
Relative Strength Index (RSI) 33.21 55.10
Support Level $17.31 $2.48
Resistance Level $22.80 $3.15
Average True Range (ATR) 0.86 0.22
MACD -0.13 -0.02
Stochastic Oscillator 23.21 34.58

Price Performance

Historical Comparison
LWAY
ELDN

About LWAY Lifeway Foods Inc.

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: